What is he best known for?
The fields of study Chung-Hang Leung is best known for:
Chung-Hang Leung integrates many fields, such as Biochemistry and Pharmacology, in his works.
He conducted interdisciplinary study in his works that combined Pharmacology and Biochemistry.
His studies link Iridium with Catalysis.
His Iridium study frequently links to adjacent areas such as Catalysis.
His study deals with a combination of Combinatorial chemistry and Organic chemistry.
His Organic chemistry study frequently links to other fields, such as Aqueous solution.
In most of his Optoelectronics studies, his work intersects topics such as Luminescence.
Luminescence is closely attributed to Optoelectronics in his work.
He carries out multidisciplinary research, doing studies in Nanotechnology and DNA.
His most cited work include:
- Bioactive Luminescent Transition-Metal Complexes for Biomedical Applications (319 citations)
- Recent advances in luminescent heavy metal complexes for sensing (249 citations)
- Bioactive iridium and rhodium complexes as therapeutic agents (239 citations)
What are the main themes of his work throughout his whole career to date
Chung-Hang Leung conducted interdisciplinary study in his works that combined Biochemistry and Pharmacology.
His Catalysis study frequently involves adjacent topics like Iridium.
His Iridium study frequently draws connections to adjacent fields such as Catalysis.
By researching both Organic chemistry and Combinatorial chemistry, Chung-Hang Leung produces research that crosses academic boundaries.
He integrates many fields, such as Combinatorial chemistry and Organic chemistry, in his works.
Optoelectronics is frequently linked to Luminescence in his study.
His Luminescence study frequently links to related topics such as Optoelectronics.
He incorporates Gene and DNA in his studies.
His Chromatography study typically links adjacent topics like Detection limit.
Chung-Hang Leung most often published in these fields:
- Biochemistry (78.21%)
- Catalysis (38.91%)
- Organic chemistry (34.24%)
What were the highlights of his more recent work (between 2019-2022)?
- Biochemistry (71.43%)
- Cancer research (42.86%)
- Cancer (38.10%)
In recent works Chung-Hang Leung was focusing on the following fields of study:
His work on Ecology as part of general Contamination research is frequently linked to Nanotechnology, bridging the gap between disciplines.
Ecology is frequently linked to Contamination in his study.
Biochemistry and Organic chemistry are two areas of study in which he engages in interdisciplinary research.
He integrates many fields, such as Organic chemistry and Biochemistry, in his works.
Chung-Hang Leung integrates Cancer research and Metastasis in his research.
By researching both Metastasis and Cancer, Chung-Hang Leung produces research that crosses academic boundaries.
With his scientific publications, his incorporates both Cancer and Immunology.
His Leukemia research extends to the thematically linked field of Immunology.
While working on this project, he studies both Leukemia and Cancer research.
Between 2019 and 2022, his most popular works were:
- A small molecule HIF-1α stabilizer that accelerates diabetic wound healing (53 citations)
- The emerging role of KDM5A in human cancer (42 citations)
- The design and development of covalent protein-protein interaction inhibitors for cancer treatment (39 citations)
In his most recent research, the most cited works focused on:
His Organic chemistry study frequently draws connections to adjacent fields such as Covalent bond.
With his scientific publications, his incorporates both Covalent bond and Enzyme.
He incorporates Enzyme and Cysteine in his research.
His study on Cysteine is mostly dedicated to connecting different topics, such as Organic chemistry.
He combines Biochemistry and Pharmacology in his studies.
Pharmacology and Biochemistry are two areas of study in which Chung-Hang Leung engages in interdisciplinary research.
Chung-Hang Leung incorporates Cancer research and Breast cancer in his research.
In his study, Chung-Hang Leung carries out multidisciplinary Breast cancer and Triple-negative breast cancer research.
In his study, Chung-Hang Leung carries out multidisciplinary Triple-negative breast cancer and Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
